297 related articles for article (PubMed ID: 22458763)
1. Pyruvate fuels mitochondrial respiration and proliferation of breast cancer cells: effect of monocarboxylate transporter inhibition.
Diers AR; Broniowska KA; Chang CF; Hogg N
Biochem J; 2012 Jun; 444(3):561-71. PubMed ID: 22458763
[TBL] [Abstract][Full Text] [Related]
2. S-Nitrosation of monocarboxylate transporter 1: inhibition of pyruvate-fueled respiration and proliferation of breast cancer cells.
Diers AR; Broniowska KA; Chang CF; Hill RB; Hogg N
Free Radic Biol Med; 2014 Apr; 69():229-38. PubMed ID: 24486553
[TBL] [Abstract][Full Text] [Related]
3. The anti-tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters.
Nancolas B; Guo L; Zhou R; Nath K; Nelson DS; Leeper DB; Blair IA; Glickson JD; Halestrap AP
Biochem J; 2016 Apr; 473(7):929-36. PubMed ID: 26831515
[TBL] [Abstract][Full Text] [Related]
4. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.
Hong CS; Graham NA; Gu W; Espindola Camacho C; Mah V; Maresh EL; Alavi M; Bagryanova L; Krotee PAL; Gardner BK; Behbahan IS; Horvath S; Chia D; Mellinghoff IK; Hurvitz SA; Dubinett SM; Critchlow SE; Kurdistani SK; Goodglick L; Braas D; Graeber TG; Christofk HR
Cell Rep; 2016 Feb; 14(7):1590-1601. PubMed ID: 26876179
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial pyruvate carrier function and cancer metabolism.
Rauckhorst AJ; Taylor EB
Curr Opin Genet Dev; 2016 Jun; 38():102-109. PubMed ID: 27269731
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of antineoplastic activity of lonidamine.
Nath K; Guo L; Nancolas B; Nelson DS; Shestov AA; Lee SC; Roman J; Zhou R; Leeper DB; Halestrap AP; Blair IA; Glickson JD
Biochim Biophys Acta; 2016 Dec; 1866(2):151-162. PubMed ID: 27497601
[TBL] [Abstract][Full Text] [Related]
7. The Multifaceted Pyruvate Metabolism: Role of the Mitochondrial Pyruvate Carrier.
Zangari J; Petrelli F; Maillot B; Martinou JC
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708919
[TBL] [Abstract][Full Text] [Related]
8. In Vitro and In Vivo Efficacy of AZD3965 and Alpha-Cyano-4-Hydroxycinnamic Acid in the Murine 4T1 Breast Tumor Model.
Guan X; Morris ME
AAPS J; 2020 Jun; 22(4):84. PubMed ID: 32529599
[TBL] [Abstract][Full Text] [Related]
9. Retinal function loss after monocarboxylate transport inhibition.
Bui BV; Kalloniatis M; Vingrys AJ
Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):584-93. PubMed ID: 14744902
[TBL] [Abstract][Full Text] [Related]
10. Cellular Uptake of MCT1 Inhibitors AR-C155858 and AZD3965 and Their Effects on MCT-Mediated Transport of L-Lactate in Murine 4T1 Breast Tumor Cancer Cells.
Guan X; Rodriguez-Cruz V; Morris ME
AAPS J; 2019 Jan; 21(2):13. PubMed ID: 30617815
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of hyperpolarized 13C1-pyruvate transport and metabolism in living human breast cancer cells.
Harris T; Eliyahu G; Frydman L; Degani H
Proc Natl Acad Sci U S A; 2009 Oct; 106(43):18131-6. PubMed ID: 19826085
[TBL] [Abstract][Full Text] [Related]
12. Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects.
Corbet C; Bastien E; Draoui N; Doix B; Mignion L; Jordan BF; Marchand A; Vanherck JC; Chaltin P; Schakman O; Becker HM; Riant O; Feron O
Nat Commun; 2018 Mar; 9(1):1208. PubMed ID: 29572438
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivities to lactate transport inhibitors of breast cancer cell lines.
Morais-Santos F; Miranda-Gonçalves V; Pinheiro S; Vieira AF; Paredes J; Schmitt FC; Baltazar F; Pinheiro C
Endocr Relat Cancer; 2014 Feb; 21(1):27-38. PubMed ID: 24174370
[TBL] [Abstract][Full Text] [Related]
14. Development of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer Treatment.
Nelson GL; Ronayne CT; Solano LN; Jonnalagadda SK; Jonnalagadda S; Rumbley J; Holy J; Rose-Hellekant T; Drewes LR; Mereddy VR
Sci Rep; 2019 Dec; 9(1):18266. PubMed ID: 31797891
[TBL] [Abstract][Full Text] [Related]
15. Troglitazone exerts metabolic and antitumor effects on T47D breast cancer cells by suppressing mitochondrial pyruvate availability.
Jung KH; Lee JH; Park JW; Moon SH; Cho YS; Lee KH
Oncol Rep; 2020 Feb; 43(2):711-717. PubMed ID: 31894283
[TBL] [Abstract][Full Text] [Related]
16. Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism.
Schell JC; Wisidagama DR; Bensard C; Zhao H; Wei P; Tanner J; Flores A; Mohlman J; Sorensen LK; Earl CS; Olson KA; Miao R; Waller TC; Delker D; Kanth P; Jiang L; DeBerardinis RJ; Bronner MP; Li DY; Cox JE; Christofk HR; Lowry WE; Thummel CS; Rutter J
Nat Cell Biol; 2017 Sep; 19(9):1027-1036. PubMed ID: 28812582
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometry analysis shows the biosynthetic pathways supported by pyruvate carboxylase in highly invasive breast cancer cells.
Phannasil P; Ansari IH; El Azzouny M; Longacre MJ; Rattanapornsompong K; Burant CF; MacDonald MJ; Jitrapakdee S
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):537-551. PubMed ID: 27890529
[TBL] [Abstract][Full Text] [Related]
18. Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease.
Felmlee MA; Jones RS; Rodriguez-Cruz V; Follman KE; Morris ME
Pharmacol Rev; 2020 Apr; 72(2):466-485. PubMed ID: 32144120
[TBL] [Abstract][Full Text] [Related]
19. The monocarboxylate transporter inhibitor α-cyano-4-hydroxycinnamic acid disrupts rat lung branching.
Granja S; Morais-Santos F; Miranda-Gonçalves V; Viana-Ferreira M; Nogueira R; Nogueira-Silva C; Correia-Pinto J; Baltazar F
Cell Physiol Biochem; 2013; 32(6):1845-56. PubMed ID: 24356196
[TBL] [Abstract][Full Text] [Related]
20. The putative monocarboxylate permeases of the yeast Saccharomyces cerevisiae do not transport monocarboxylic acids across the plasma membrane.
Makuc J; Paiva S; Schauen M; Krämer R; André B; Casal M; Leão C; Boles E
Yeast; 2001 Sep; 18(12):1131-43. PubMed ID: 11536335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
